Filing metadata

Accession number
0001209191-21-006934
Form type
Form 4
Filer
Oyster Point Pharma, Inc.
CIK
CIK 1720725
Filed
Feb 02, 2021
Reporting period
Jan 29, 2021
Description
Insider transaction

Explore SEC Filings Hub